UNITEDHEALTH GROUP INC. REGISTERED SHARES DL -,01
Technische Signale
| Signale Details | |
|---|---|
| WKN / ISIN | - / US91324P1021 |
| Börse | Berlin |
| Schluss | 512,70 |
| Spekulatives Signal |  01.10.24 |
| MACD | 02.10.24 |
| Momentum | 11.10.24 |
| Bollinger Bands |  31.05.24 |
| TBI | 03.10.24 |
| Schnitt GD 90 | 22.10.24 |
Analystenbewertung
| Bewertungstrend | aktuell | Vorwoche | Vormonat |
|---|---|---|---|
| Bewertung | 1,39 | 1,39 | 1,30 |
| Anzahl der Analysten | 28 | 28 | 27 |
| Kaufen | 20 | 20 | 20 |
| Übergewichten | 5 | 5 | 6 |
| Halten | 3 | 3 | 1 |
| Untergewichten | 0 | 0 | 0 |
| Verkaufen | 0 | 0 | 0 |
| Aktueller Durchschnitt von insgesamt 28 Analysten: 1,39 | |||
| Planzahlen (in EUR) | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Umsatz | 371,62 Mrd. | 398,96 Mrd. | 429,19 Mrd. |
| EBIT | 29,73 Mio. | 35,11 Mrd. | 39,35 Mrd. |
| EBITDA | 33,38 Mio. | 38,71 Mrd. | 43,43 Mrd. |
| Nettoverschuldung** | 28,67 Mrd. | 27,18 Mrd. | 11,65 Mrd. |
Umsatz |
EBIT |
EBITDA |
Nettoverschuldung** |
| Dividende | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Dividende / Aktie | 6,70 EUR | 7,88 USD | 8,72 USD |
| Dividendenrendite | 1,31% | 1,39% | 1,54% |
Dividende / Aktie (in USD) |
Dividendenrendite (in %) |
||
| Analystenhäuser |
|---|
| Argus Research Company,Baird,Barclays,BMO Capital Markets Equity Research,BMO Capital Markets U.S. (Historical),BofA Global Research,Cantor Fitzgerald & Co.,CFRA Equity Research,Citadel Securities, LLC,Citigroup Inc,Cleveland Research Company,Collins Stewart LLC,Credit Suisse,Crisp Idea,CRT Capital Group,Deutsche Bank,Equisights,Evercore ISI,FBR Capital Markets & Co.,Gleacher & Company, Inc.,Goldman Sachs,Hanwha Investment & Securities Co., Ltd.,HSBC,Inside Research S.A.,J.P. Morgan,Jefferies LLC,KB Securities Co., Ltd.,KeyBanc Capital Markets Inc.,Lazard Capital Markets,Leerink Partners LLC,Loop Capital Markets,Miller Tabak & Co., LLC,Mirae Asset Securities Co., Ltd.,Mizuho Securities USA LLC,Morgan Stanley,Morningstar Inc.,NH Investment & Securities Co., Ltd.,Oppenheimer & Co. Inc.,Piper Sandler Companies,Raymond James & Associates,RBC Capital Markets,Samsung Securities Co. Ltd.,Sanford C. Bernstein & Co., LLC,Seaport Research Partners,Siebert Williams Shank & Co., LLC,Stephens, Inc.,Sterne Agee & Leach,Stifel, Equities Research,Susquehanna Financial Group, LLLP,TD Cowen,Truist Securities,UBS Investment Bank,Wedbush Securities Inc.,Wells Fargo Securities, LLC,Wolfe Research, LLC.,Zephirin Group, Inc. |
| Hinweis |
|---|
|
Selected Data supplied by Standard & Poors
* Unabhängige Schätzung (Gewinnwachstum (in %)) ** Nettobargeldbestand bei negativen Schätzungen |